Carolina Alves vs Sara Alejandra Lozano Avellaneda Odds Comparison - WTA Sopo
Teams: Carolina Alves vs Sara Alejandra Lozano Avellaneda
Competition: WTA Sopo
Sport: Tennis
Region: WTA
Starts (UTC):
Match status: Not started
Odds
Typical 1X2 prices (averages across listed bookmakers): home ~1.03, away ~10.00.
Markets with odds data in this feed: 1X2.
| Bookmaker | Carolina Alves | Sara Alejandra Lozano Avellaneda |
|---|---|---|
| Bet365 | 1.03 | 10.00 |
H2H
Recent form and head-to-head for Carolina Alves vs Sara Alejandra Lozano Avellaneda (static summary for search engines).
Recent matches — Carolina Alves
- 4 Nov 2026 · Leolia Jeanjean — 6-1,6-4 — Carolina Alves
- 2 Nov 2026 · Carolina Alves — 6-1,6-0 — Maria Paulina Perez Garcia
- 27 Oct 2026 · Carolina Alves — 5-7,6-7 — Julia Grabher
- 18 Oct 2026 · Carolina Alves — 5-7,5-7 — Alena Kovackova
- 17 Oct 2026 · Valeriia Artemeva — 5-7,3-6 — Carolina Alves
- 16 Oct 2026 · Gala Ivanovic — 2-6,3-6 — Carolina Alves
- 13 Oct 2026 · Daniella Dimitrova — 2-6,6-2,0-6 — Carolina Alves
- 8 Oct 2026 · Carolina Alves — 3-6,4-6 — Luisina Giovannini
- 7 Oct 2026 · Carolina Alves — 6-2,6-3 — Denislava Glushkova
- 16 Sept 2026 · Suzan Lamens — 3-6,7-6,6-2 — Carolina Alves
Recent matches — Sara Alejandra Lozano Avellaneda
- 29 Mar 2026 · Jazmin Ortenzi — 6-2,6-0 — Sara Alejandra Lozano Avellaneda
About this match
Carolina Alves comes into Sopo with two wins from her last five matches, a sequence that includes defeats to Leolia Jeanjean, Julia Grabher and Alena Kovackova alongside victories over Maria Paulina Perez Garcia and Valeriia Artemeva. That is a modest return, yet the WTA Sopo odds install her as a clear favourite.
At the other end, Sara Alejandra Lozano Avellaneda has just one recent result to look at: a loss to Jazmin Ortenzi. A single match is a thin basis for judging form, and it leaves the higher-priced player's current level largely unmeasured.
The contrast is what stands out. The market's confidence in the favourite runs well ahead of what her recent results alone would suggest, while the underdog arrives with almost no recent evidence either way. One side is priced decisively; the other is barely documented. A two-win run in five is not alarming on its own, but it sits awkwardly beside such a decisive price. Early prices set the hierarchy, yet the form lines behind it are thinner than that gap implies, which makes the size of the favourite's advantage the point to weigh rather than assume.